Printer Friendly

Articles from M2 Pharma (May 28, 2018)

1-12 out of 12 article(s)
Title Author Type Words
ALK-Abello presents phase III data on tree SLIT-tablet at EAACI Annual Congress in Munich. 419
Avara Pharmaceutical Services to acquire sterile manufacturing facility for injectable medicines. 187
Beactica extends agreement with Sanofi. 139
BioMarin receives approval from USFDA for Palynziq. 144
Braeburn resubmits CAM2038 NDA with US FDA for additional review for opioid use disorder. 245
Genmab reports stopping of studies of Daratumumab in combination with anti-PD-(L)1 by Janssen. 385
Indivior updates the regulatory submission of SUBLOCADE Injection for opioid dependence in Australia. 195
Lion TCR announces USD20m from Series A financing round. 155
Lion TCR raises USD20m in Series A financing round. 234
Luye Pharma closes acquisition of signature products Seroquel and Seroquel XR. 233
Sandoz's Zessly receives approval from European Commission. 147
USANA announces expansion of research and development team. 224

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters